RBC Capital Maintains Sector Perform on Sarepta Therapeutics, Raises Price Target to $18
Sarepta Therapeutics Inc (SRPT) Q3 2026 Earnings Call Highlights: Revenue Guidance Raised ...
Compared to Estimates, Sarepta Therapeutics (SRPT) Q3 Earnings: A Look at Key Metrics
Loading...